166 related articles for article (PubMed ID: 37800814)
21. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
Yan S; Fang J; Chen Y; Xie Y; Zhang S; Zhu X; Fang F
BMC Cancer; 2020 Dec; 20(1):1205. PubMed ID: 33287740
[TBL] [Abstract][Full Text] [Related]
22. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
23. Identification of Key Inflammation-related Genes as Potential Diagnostic Biomarkers of Sepsis.
Guo P; Wang R; Shen J; Zhang L; Mo W
Altern Ther Health Med; 2023 Jul; 29(5):24-31. PubMed ID: 37235492
[TBL] [Abstract][Full Text] [Related]
24. Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.
Liu Q; Zhang H; Yang X; Liu X; Yin F; Guo P; Yin Y; Zheng K; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):126. PubMed ID: 35282039
[TBL] [Abstract][Full Text] [Related]
25. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
26. Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy.
Li Z; Duan Y; Ke Q; Wang M; Cen H; Zhu X
Front Genet; 2022; 13():1000460. PubMed ID: 36276947
[No Abstract] [Full Text] [Related]
27. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract][Full Text] [Related]
28. System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer.
Shi T; Yan R; Han MI
Oncol Res; 2023; 31(4):591-604. PubMed ID: 37415732
[TBL] [Abstract][Full Text] [Related]
29. Identification of immune microenvironment changes, immune-related pathways and genes in male androgenetic alopecia.
Xiong HD; Tang LL; Chen HJ; Wu Y; Li WY; Wen SJ; Lin YK
Medicine (Baltimore); 2023 Sep; 102(38):e35242. PubMed ID: 37746940
[TBL] [Abstract][Full Text] [Related]
30. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
31. Construction of an Immunity and Ferroptosis-Related Risk Score Model to Predict Ovarian Cancer Clinical Outcomes and Immune Microenvironment.
Wei C; Zhao G; Gao M; Liu Y; Lei P; Cao T
Front Biosci (Landmark Ed); 2023 Jan; 28(1):4. PubMed ID: 36722270
[TBL] [Abstract][Full Text] [Related]
32. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
33. [Bioinformatics analysis of programmed cell death ligand 1 co-expression genes and their regulatory network in head and neck squamous cell carcinoma].
Yang LS; Shi CY; Liang YH; Liu T; Hou XR; Tian XD; Wang XY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Oct; 37(5):516-520. PubMed ID: 31721500
[TBL] [Abstract][Full Text] [Related]
34. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.
Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G
BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375
[TBL] [Abstract][Full Text] [Related]
35. Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis.
Meng H; Long Q; Wang R; Zhou X; Su H; Wang T; Li Y
Int J Chron Obstruct Pulmon Dis; 2022; 17():13-24. PubMed ID: 35018096
[TBL] [Abstract][Full Text] [Related]
36. Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms.
Kadkhoda S; Darbeheshti F; Tavakkoly-Bazzaz J
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1286. PubMed ID: 32886452
[TBL] [Abstract][Full Text] [Related]
37. Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA.
Su R; Jin C; Zhou L; Cao Y; Kuang M; Li L; Xiang J
BMC Cancer; 2021 Aug; 21(1):970. PubMed ID: 34461858
[TBL] [Abstract][Full Text] [Related]
38. Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis.
Zhang X; Han L; Zhang H; Niu Y; Liang R
Heliyon; 2023 Aug; 9(8):e19208. PubMed ID: 37664697
[TBL] [Abstract][Full Text] [Related]
39. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.
Yu L; Ding Y; Wan T; Deng T; Huang H; Liu J
Front Immunol; 2021; 12():768115. PubMed ID: 34966389
[TBL] [Abstract][Full Text] [Related]
40. Identification and Analysis of Potential Immune-Related Biomarkers in Endometriosis.
He Y; Li J; Qu Y; Sun L; Zhao X; Wu H; Zhang G
J Immunol Res; 2023; 2023():2975581. PubMed ID: 36660246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
